ANVS - Annovis Bio Inc Stock Price, Fair Value and News

$4.64+0.23 (+5.22%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ANVS Price Action

Last 7 days

-5.7%

Last 30 days

129.7%

Last 90 days

103.5%

Trailing 12 Months

-27.4%

ANVS RSI Chart

ANVS Valuation

Market Cap

123.0M

Price/Earnings (Trailing)

-4.94

Price/Sales (Trailing)

3.7K

EV/EBITDA

-2.93

Price/Free Cashflow

-4.92

ANVS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ANVS Fundamentals

ANVS Revenue

Revenue (TTM)

36.8K

ANVS Earnings

Earnings (TTM)

-24.9M

Earnings Growth (Yr)

42.53%

Earnings Growth (Qtr)

-16.76%

ANVS Profitability

EBT Margin

-111386.81%

Return on Equity

-189.15%

Return on Assets

-144.77%

Free Cashflow Yield

-20.31%

ANVS Investor Care

Shares Dilution (1Y)

92.09%

Diluted EPS (TTM)

-1.31

ANVS Alerts

2 major insider buys recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2021	877.3K	597.1K	316.9K	36.8K
2020	840.7K	946.3K	1.1M	1.2M
2019	0	0	0	735.1K

Get all data in R, Python etc through our Historical Stock Data APIs

About Annovis Bio Inc

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

CEO	Dr. Maria L. Maccecchini Ph.D.
WEBSITE	annovisbio.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	5

Annovis Bio Inc Frequently Asked Questions

What is the ticker symbol for Annovis Bio Inc? What does ANVS stand for in stocks?

ANVS is the stock ticker symbol of Annovis Bio Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Annovis Bio Inc (ANVS)?

As of Wed Dec 03 2025, market cap of Annovis Bio Inc is 122.97 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ANVS stock?

You can check ANVS's fair value in chart for subscribers.

Is Annovis Bio Inc a good stock to buy?

The fair value guage provides a quick view whether ANVS is over valued or under valued. Whether Annovis Bio Inc is cheap or expensive depends on the assumptions which impact Annovis Bio Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ANVS.

What is Annovis Bio Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, ANVS's PE ratio (Price to Earnings) is -4.94 and Price to Sales (PS) ratio is 3.68 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ANVS PE ratio will change depending on the future growth rate expectations of investors.